Comparative Risk of Major Congenital Malformations With Antiseizure Medication Combinations vs Valproate Monotherapy in Pregnancy-Reference-Cited by-同舟云学术

Comparative Risk of Major Congenital Malformations With Antiseizure Medication Combinations vs Valproate Monotherapy in Pregnancy

Published:2024-01-23 Issue:2 Volume:102 Page:
ISSN:0028-3878
Container-title:Neurology
language:en
Short-container-title:Neurology

Author:

Cohen Jacqueline M.¹^ORCID,Alvestad Silje¹^ORCID,Suarez Elizabeth A.¹^ORCID,Schaffer Andrea¹^ORCID,Selmer Randi M.¹^ORCID,Havard Alys¹^ORCID,Bateman Brian T.¹^ORCID,Cesta Carolyn E.¹^ORCID,Zoega Helga¹^ORCID,Odsbu Ingvild¹^ORCID,Huybrechts Krista F.¹^ORCID,Kjerpeseth Lars J.¹^ORCID,Straub Loreen¹^ORCID,Leinonen Maarit K.¹^ORCID,Bjørk Marte-Helene¹^ORCID,Nørgaard Mette¹^ORCID,Gissler Mika¹^ORCID,Ulrichsen Sinna P.¹^ORCID,Hernandez-Diaz Sonia¹^ORCID,Tomson Torbjörn¹^ORCID,Furu Kari¹^ORCID

Affiliation:

1. From the Department of Chronic Diseases (J.M.C., R.M.S., I.O., L.J.K., K.F.) and Centre for Fertility and Health (J.M.C., K.F.), Norwegian Institute of Public Health, Oslo; Department of Clinical Medicine (S.A., M.-H.B.), University of Bergen, Norway; National Center for Epilepsy (S.A.), Oslo University Hospital, Norway; Division of Pharmacoepidemiology and Pharmacoeconomics (E.A.S., B.T.B., K.F.H., L.S.), Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA;...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical)

Link

https://www.neurology.org/doi/pdfdirect/10.1212/WNL.0000000000207996

Reference41 articles.

1. Health Canada. Valproate anti-epileptic drugs may pose risks to children when taken by mothers during pregnancy [online]. Accessed April 12 2019. healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2011/13625a-eng.php.

2. U.S. Food & Drug Administration. FDA Drug Safety Communication: children born to mothers who took Valproate products while pregnant may have impaired cognitive development [6-30-2011] [online]. Accessed December 3 2018. www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-children-born-mothers-who-took-valproate-products-while-pregnant-may

3. U.S. Food & Drug Administration. FDA Drug Safety Communication: valproate anti-seizure products contraindicated for migraine prevention in pregnant women due to decreased IQ scores in exposed children [05-06-2013] [online]. Accessed December 3 2018. www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-valproate-anti-seizure-products-contraindicated-migraine-prevention

4. European Medicines Agency. PRAC recommends strengthening the restrictions on the use of valproate in women and girls [EMA/612389/2014] [online]. Accessed March 12 2018. www.ema.europa.eu/en/documents/press-release/prac-recommends-strengthening-restrictions-use-valproate-women-girls_en.pdf

5. European Medicines Agency. New measures to avoid valproate exposure in pregnancy endorsed [EMA/375438/2018] [online]. Accessed March 12 2018. www.ema.europa.eu/en/documents/press-release/new-measures-avoid-valproate-exposure-pregnancy-endorsed_en.pdf

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lamotrigine vs levetiracetam in female patients of childbearing age with juvenile absence epilepsy: A Bayesian reanalysis;Epilepsia;2024-08-10

2. Preconception counselling in women with epilepsy;Practical Neurology;2024-06-27

3. Depression Treatment in Pregnancy: Is It Safe, or Is It Not?;International Journal of Environmental Research and Public Health;2024-03-26